Pillar Biosciences Receives Premarket Approval from FDA for its oncoReveal Dx Lung and Colon Cancer Assay
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection
Sickle Cell Disease Support Corner developed to create a database of individuals with sickle cell disease
CDSCO to fast-track trials and approval for COVID19 vaccine
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
Innovative solutions and a deep understanding of the market makes this a unique combination
Five seats reserved for Wards of COVID warriors in central MBBS admission
It supports sequencing-based COVID 19 surveillance in India
Ayush Ministry will conduct the study along with the UK’s London School of Hygiene and Tropical Medicine
WHO prequalification enables the procurement of ROTAVAC 5D by UN agencies namely UNICEF and PAHO
Subscribe To Our Newsletter & Stay Updated